New federal regulations and the future practice of cytology.
An explanation of the new federal economic initiatives (the Tax Equity and Fiscal Responsibility Act; diagnosis-related groups) is offered as they currently pertain to the practice of cytopathology. Future trends are discussed, and means to deal with them are recommended. The cytology community can wait no longer to come to grips with changing economic times.